Blackrock Inc vs DexCom, Inc. — how do they compare? Blackrock Inc trades at $1,144.15 (market cap $175.22B), while DexCom, Inc. trades at $89.53 (market cap $33.08B). The key difference: Blackrock Inc is far larger — about 5.3× DexCom, Inc.'s market cap, and Blackrock Inc pays a 2.03% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| BLK | DXCM | |
|---|---|---|
Market Cap | $175.22B | $33.08B |
Volume | 641,547 | — |
Sector | Financials | Health |
52-Week High | $1.20K | $89.53 |
52-Week Low | $922.90 | $54.84 |
Enterprise Value | $176.32B | $32.53B |
Dividend Yield | 2.03% | — |
Signals from Pluang's Aura AI — not financial advice
BlackRock (BLK) trades at $1,136.39, up 0.63% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with revenue growth from $20.4B in 2024 to $24.2B in 2025, though net income margin compressed to 22.93%. Recent earnings beats and a 78.79% analyst buy rating support positive sentiment, while the stock trades near resistance at $1,144.
BLK presents a compelling investment case with consistent earnings outperformance and strong institutional support, though investors face risks from margin compression and legal scrutiny. The consensus price target of $1,350 suggests 18.8% upside potential, balanced by overbought technical indicators and competitive pressures in asset management.
DXCM trades at $84.75, up 2.08% today and near its 52-week high. The stock shows bullish technical momentum with strong earnings beats in recent quarters, including Q2 2026 EPS of $0.70 versus $0.61 expected. Revenue growth accelerated to 13% year-over-year in Q2 2026, driven by G7 system adoption and international expansion. Cash flow from operations improved to $1.44 billion in 2025, supporting financial flexibility.
Outlook remains positive with raised FY2026 guidance and 80% analyst buy ratings, though valuation multiples like P/E of 33.5 suggest premium pricing. Key risks include competitive pressures in glucose monitoring and reliance on reimbursement policies. The consensus price target of $88.65 implies modest upside from current levels.
Trailing returns across standard periods
Latest headlines on both assets
BlackRock, Inc. provides investment management services to institutional clients and to retail investors through various investment vehicles. The Company manages funds, as well as offers risk management services. BlackRock serves governments, companies, and foundations worldwide.
Read more on BLK →Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →